ctrl K

RayzeBio Inc. Common Stoc... (RYZB)

NASDAQ: RYZB · Real-Time Price · USD

62.49

0.01 (0.02%)

At close: Feb 23, 2024, 9:00 PM

RayzeBio Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q4 2022
Period Ending	Sep 30, 2023	Jun 30, 2023	Dec 31, 2022
Cash & Equivalents	251.96M	33.21M	129.16M
Short-Term Investments	288.2M	223.74M	167.09M
Long-Term Investments	n/a	n/a	n/a
Other Long-Term Assets	347K	1.13M	347K
Receivables	n/a	n/a	n/a
Inventory	n/a	n/a	n/a
Other Current Assets	4.82M	3.59M	3.79M
Total Current Assets	544.99M	260.55M	300.04M
Property-Plant & Equipment	58.18M	44.09M	24.39M
Goodwill & Intangibles	n/a	n/a	n/a
Total Long-Term Assets	58.53M	45.22M	24.74M
Total Assets	603.51M	305.76M	324.78M
Account Payables	2.24M	2.43M	2.62M
Deferred Revenue	n/a	n/a	n/a
Short-Term Debt	1.27M	1.23M	1.14M
Other Current Liabilities	13.61M	11M	6.69M
Total Current Liabilities	17.11M	14.66M	10.46M
Long-Term Debt	8.46M	8.79M	9.43M
Other Long-Term Liabilities	2.62M	417.81M	416.19M
Total Long-Term Liabilities	11.08M	426.59M	425.61M
Total Liabilities	28.19M	441.25M	436.07M
Total Debt	9.72M	10.01M	10.57M
Common Stock	6K	3K	2K
Retained Earnings	-180.13M	-160.73M	-130.12M
Comprehensive Income	-386K	-566K	-553K
Shareholders Equity	575.32M	-135.49M	-111.29M
Total Investments	288.2M	223.74M	167.09M